Target intelligence / Profile preview

CCDC13 antisense RNA 1 (CCDC13-AS1)

Target
CCDC13-AS1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

CCDC13 antisense RNA 1 (CCDC13-AS1) is a long non-coding RNA transcribed from the antisense strand of the CCDC13 gene locus, located on chromosome 10[7]. It is also called LINC01352. Through transcriptome profiling studies—including some related to Alzheimer's disease—CCDC13-AS1 has been detected as a non-coding RNA expressed in human tissues, but its specific function, regulatory targets, or molecular mechanisms remain unknown[3][4][7]. No literature links CCDC13-AS1 to direct biological roles, disease phenotypes, or responses to therapeutic intervention. Its presence appears to be of current research interest primarily for gene expression profiling or as a candidate regulatory RNA, rather than as a receptor, enzyme, or other druggable entity. If structured information is later desired, there is currently not enough evidence to justify its classification as a drug target, biomarker, or therapeutic entity. The entry is correct but the current lack of mechanistic and functional evidence should be noted.

Other names
CCDC13-AS1LINC01352CCDC13 antisense RNA 1 (non-protein coding)CCDC13-AS1 RNA
02

Mechanism of action

Not established No mechanisms of drug action described for this lncRNA.

03

Biological functions

UnknownFunction currently undetermined; no well-established biological roles.May participate in gene regulation, as other antisense lncRNAs do, but this is currently speculative for CCDC13-AS1.
04

Disease associations

Unknown/OtherNo established association with specific disease processes.Has been profiled among many lncRNAs in Alzheimer’s disease transcriptome studies, but a direct role is not established.
05

Safety considerations

None reportedNot clinically targeted, so no safety profile available.
06

Interacting drugs

None known
07

Biomarkers

None knownNot described as a biomarker for disease or drug response

Beyond the preview

Go deeper on CCDC13 antisense RNA 1 (CCDC13-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCDC13 antisense RNA 1 (CCDC13-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call